Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/5/2025

Medication Adjustment for Persistent Anxiety

Rationale for Medication Adjustment

  • The American Academy of Child and Adolescent Psychiatry identifies SSRIs as first-line pharmacotherapy for anxiety disorders with superior efficacy to buspirone, and buspirone is generally reserved for patients who cannot tolerate SSRIs or when avoiding sedation is paramount 1, 2, 3

Dosing Strategy

  • Prioritize optimizing buspirone first, as it is currently underdosed, while vortioxetine is at a reasonable therapeutic level, according to Praxis Medical Insights 1

Critical Pitfalls to Avoid

  • Do not abandon buspirone prematurely, as the medication requires 2-4 weeks to demonstrate full anxiolytic effect, and the current dose is subtherapeutic 1
  • Do not add benzodiazepines for chronic management, as they carry dependence risk and are inappropriate for ongoing treatment 2

REFERENCES

1

Buspirone Dosing and Treatment for Anxiety [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Comorbid Anxiety with Lurasidone [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025